HealthyDirect · GrowthFit for a long SIP
Baroda BNP Paribas Multi Asset Active Fund of Funds
Baroda BNP Paribas Mutual FundFund of Funds Scheme (Domestic) - Fund of Funds Scheme (Domestic)1.4 years
- NAV
- 11.2393
- 29 Oct 2026
- 1Y
- +5.1%
- Trailing CAGR
- AUM
- ₹110.61 Cr
- 30 Sept 2026
- Volatility
- Medium
- 8.3% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 97% of rolling 1-year windows.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Fail
1.4 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.27% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -8.3%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 100.0% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+5.1%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+8.6%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+0.0%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +8.6%
- Calendar-day CAGR
- Excess 1Y
- +0.6%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -8.3%
- Worst peak-to-trough
- Current
- -4.5%
- Below last peak
- Current spell
- 273 days
- Days below latest peak
- Time below peak
- +87%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 8 days
- 18 recovered episodes
- Longest recovery
- 34 days
- Trough to prior peak
29 Jan 2026 – open
Trough 23 Mar 2026 · not recovered
-8.3%
17 Oct 2025 – 1 Dec 2025
Trough 28 Oct 2025 · recovered in 34 days
-2.7%
9 Sept 2025 – 1 Oct 2025
Trough 11 Sept 2025 · recovered in 20 days
-1.4%
21 Jan 2026 – 28 Jan 2026
Trough 22 Jan 2026 · recovered in 6 days
-1.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
34
Vs category
54
Consistency
97
Risk-adjusted
42
Drawdown
79
Mean
61
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 97% of rolling 1-year windows.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 5 holdings · top 10 are 100.0%.
- Top 5
- 100.2%
- Top 10
- 100.0%
- Largest holding
- 52.1%
- Effective holdings
- 2.8
Baroda BNP Paribas Short Term Fund Direct-Growth
Unspecified
52.1%
BNP Paribas Equity Direct-Growth
Unspecified
20.0%
Baroda BNP Paribas Gold ETF - Growth
Unspecified
19.6%
Baroda BNP Paribas Dynamic Term Fund Direct-Growth
Unspecified
7.8%
Others CBLO
Unspecified
0.6%
What changed
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
DECISION
Status moved from HEALTHY to MONITOR.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Silver Fund of Fund
Axis Mutual Fund
- 1Y
- +27.9%
- 3Y
- +36.6%
- Vol
- 35.1%
- Max DD
- -49.4%
- Sharpe
- 0.87
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Baroda BNP Paribas Gold ETF Fund of Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +16.3%
- 3Y
- n/a
- Vol
- 33.1%
- Max DD
- -26.0%
- Sharpe
- 0.86
- 3Y win
- n/a
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
UTI Silver ETF Fund of Fund
UTI Mutual Fund
- 1Y
- +27.8%
- 3Y
- +36.7%
- Vol
- 37.9%
- Max DD
- -48.6%
- Sharpe
- 0.67
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Zerodha Silver ETF FoF
Zerodha Mutual Fund
- 1Y
- +27.1%
- 3Y
- n/a
- Vol
- 54.4%
- Max DD
- -49.7%
- Sharpe
- 0.92
- 3Y win
- n/a
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
UTI Income Plus Arbitrage Active Fund of Fund
UTI Mutual Fund
- 1Y
- +4.8%
- 3Y
- n/a
- Vol
- 0.9%
- Max DD
- -0.3%
- Sharpe
- -0.36
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns